KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Inventory (2016 - 2022)

TherapeuticsMD's Change in Inventory history spans 12 years, with the latest figure at $551000.0 for Q3 2022.

  • For Q3 2022, Change in Inventory rose 49.73% year-over-year to $551000.0; the TTM value through Sep 2022 reached -$588000.0, down 2000.0%, while the annual FY2021 figure was $711000.0, 78.69% down from the prior year.
  • Change in Inventory reached $551000.0 in Q3 2022 per TXMD's latest filing, up from -$2.8 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $3.0 million in Q3 2019 to a low of -$2.8 million in Q2 2022.
  • Average Change in Inventory over 5 years is $714490.1, with a median of $497644.0 recorded in 2018.
  • Peak YoY movement for Change in Inventory: soared 1145.66% in 2019, then crashed 1335.53% in 2022.
  • A 5-year view of Change in Inventory shows it stood at $889449.0 in 2018, then soared by 49.29% to $1.3 million in 2019, then crashed by 136.07% to -$479000.0 in 2020, then surged by 154.28% to $260000.0 in 2021, then skyrocketed by 111.92% to $551000.0 in 2022.
  • Per Business Quant, the three most recent readings for TXMD's Change in Inventory are $551000.0 (Q3 2022), -$2.8 million (Q2 2022), and $1.4 million (Q1 2022).